Comparison of FEV1 reference equations for evaluating a cystic fibrosis therapeutic intervention

被引:7
|
作者
Konstan, Michael W. [1 ]
Wagener, Jeffrey S. [2 ]
VanDevanter, Donald R. [1 ]
Pasta, David J. [3 ]
Millar, Stefanie J. [3 ]
Morgan, Wayne J. [4 ]
机构
[1] Case Western Reserve Univ, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA
[2] Univ Colorado, Sch Med, Aurora, CO USA
[3] ICON Clin Res, San Francisco, CA USA
[4] Univ Arizona, Tucson, AZ USA
关键词
cystic fibrosis; dornase alfa; epidemiology; pulmonary function; PULMONARY-FUNCTION; REFERENCE VALUES; CLINICAL-USE; SPIROMETRY; CHILDREN; DECLINE; AGE; US;
D O I
10.1002/ppul.23751
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives: The Global Lung Function Initiative (GLI, 2012) developed reference equations for forced expiratory volume in 1 s (FEV1). Previous equations were developed by groups led by Knudson (1983), Wang (1993), Hankinson (1999), and Stanojevic (2008). 1,2,4,6 We assessed how different prediction equations affect the conclusions from a therapeutic intervention study that evaluated the rate of percent predicted FEV1 (ppFEV(1)) decline. Methodology: Using data from the Epidemiologic Study of cystic fibrosis (CF), we re-analyzed our previous study evaluating the relationship of dornase alfa (DA) use with ppFEV(1) using the Knudson, Wang & Hankinson, Stanojevic, and GLI equations. The change in intercept and change in slope of ppFEV(1) from a 2-year pre-index period and 2-year post-index period were compared between the treated (N = 2483) and comparator groups (N = 6992, from 4110 unique patients). Results: Change in intercept for the comparator group was similar across equations except that Wang& Hankinson values were more negative. The difference in change in intercept between the DA and comparator groups ranged from 3.38 to 4.02% predicted. The change in slope for the comparator group ranged from -0.58 to +0.30 ppFEV(1)/year, but the difference in change in slope between the DA and comparator groups was in a narrower range from +0.53 to +0.89 ppFEV(1)/year. Conclusions: Although individual patient results are impacted by the choice of reference equations, the study conclusions from this evaluation of a therapeutic intervention were minimally affected. GLI equations are recommended for future studies, but prior results based on other equations should be accepted as reliable.
引用
收藏
页码:1013 / 1019
页数:7
相关论文
共 50 条
  • [41] The Effect Of Longitudinal Decline In FEV1 And Number Of Exacerbations On Prognosis In A Cystic Fibrosis Cohort
    McCarthy, C.
    Dimitrov, B. D.
    Gunaratnam, C. M.
    McElvaney, N. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [42] EFFECT OF SCEDOSPORIUM APIOSPERMUM COLONIZATION ON FEV1% To TRENDS IN ADULT PATIENTS WITH CYSTIC FIBROSIS
    Rao, P.
    Kumar, S., I
    Afshar, K.
    Beringer, P.
    PEDIATRIC PULMONOLOGY, 2010, : 378 - 378
  • [43] VITAMIN D STATUS IS NOT ASSOCIATED WITH THE RATE OF DECLINE IN FEV1 % IN CHILDREN WITH CYSTIC FIBROSIS
    McPhail, G. L.
    Fenchel, M.
    VanDyke, R.
    Boesch, R. P.
    Ednick, M.
    Chini, B.
    Seid, M.
    PEDIATRIC PULMONOLOGY, 2011, : 240 - 240
  • [44] THE IMPACT OF RESPIRATORY VIRUSES AND PULMONARY EXACERBATIONS ON FEV1 DECLINE IN ADULTS WITH CYSTIC FIBROSIS
    Flight, W. G.
    Mutton, K. J.
    Webb, A. K.
    Bright-Thomas, R. J.
    Jones, A. M.
    THORAX, 2012, 67 : A101 - A102
  • [45] Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry
    Kerem, Eitan
    Viviani, Laura
    Zolin, Anna
    MacNeill, Stephanie
    Hatziagorou, Elpis
    Ellemunter, Helmut
    Drevinek, Pavel
    Gulmans, Vincent
    Krivec, Uros
    Olesen, Hanne
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (01) : 125 - 133
  • [46] Clinical use of ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis
    Konstan, Michael W.
    Schluchter, Mark D.
    Xue, Wei
    Davis, Pamela B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (11) : 1084 - 1089
  • [47] Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study
    Taylor-Robinson, David
    Whitehead, Margaret
    Diderichsen, Finn
    Olesen, Hanne Vebert
    Pressler, Tania
    Smyth, Rosalind L.
    Diggle, Peter
    THORAX, 2012, 67 (10) : 860 - 866
  • [48] INITIAL FEV1 MEASUREMENTS PREDICT FUTURE PULMONARY OUTCOME IN CHILDREN WITH CYSTIC FIBROSIS
    Com, G.
    Jambhekar, S.
    MelguizoCastro, M. S.
    Berlinski, A.
    PEDIATRIC PULMONOLOGY, 2011, : 336 - 337
  • [49] Lung Clearance Index in adult patients with atypical Cystic Fibrosis and normal FEV1
    Montiel, Almudena Felipe
    Fernandez, Antonio Alvarez
    Salvador, Laia Verdejo
    Traversi, Letizia
    Boyero, Clara Pons
    Reyes, Karina Loor
    Alarcon, David Clofent
    Amigo, Mario Culebras
    Polverino, Eva
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [50] THE EFFECT OF MAJOR PSYCHIATRIC ILLNESS ON FEV1% AND BMI IN PEDIATRIC CYSTIC FIBROSIS PATIENTS
    McCann, A.
    Livingston, F.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S398 - S398